成功使用泊沙康唑治疗由婴儿利什曼原虫引起的旧世界皮肤利什曼病。
Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.
机构信息
Department of Pathology and Laboratory Medicine, St. Luke's-Roosevelt Hospital Center (University Hospital of Columbia University College of Physicians and Surgeons), St. Luke's Division, Clark 4th floor, 1111 Amsterdam Avenue, New York, NY 10025, USA.
出版信息
Antimicrob Agents Chemother. 2011 Apr;55(4):1774-6. doi: 10.1128/AAC.01498-10. Epub 2011 Jan 31.
Abstract
Old World cutaneous leishmaniasis is a widespread and potentially disfiguring protozoal infection that is endemic in the Mediterranean basin, Africa, and parts of Asia. Human infection is caused by several species of Leishmania parasites, such as Leishmania infantum. Available systemic and topical treatments vary in efficacy and are often unjustified due to their toxicity. We report on a case that was treated with posaconazole, a drug typically considered an antifungal agent but which also targets specific metabolic pathways of the parasite.
摘要
旧大陆皮肤利什曼病是一种广泛存在且可能导致毁容的原生动物感染，在地中海盆地、非洲和亚洲部分地区流行。人类感染是由几种利什曼原虫寄生虫引起的，如利什曼原虫婴儿。现有的全身和局部治疗方法在疗效上存在差异，而且由于其毒性，往往是不合理的。我们报告了一例使用泊沙康唑治疗的病例，泊沙康唑通常被认为是一种抗真菌药物，但也针对寄生虫的特定代谢途径。
相似文献
1
Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.
Antimicrob Agents Chemother. 2011 Apr;55(4):1774-6. doi: 10.1128/AAC.01498-10. Epub 2011 Jan 31.
2
Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Pediatr Infect Dis J. 2012 Jan;31(1):97-100. doi: 10.1097/INF.0b013e31822dfbf7.
3
Leishmania infantum AS A CAUSATIVE AGENT OF CUTANEOUS LEISHMANIASIS IN THE STATE OF MATO GROSSO DO SUL, BRAZIL.
Rev Inst Med Trop Sao Paulo. 2016;58:23. doi: 10.1590/S1678-9946201658023. Epub 2016 Mar 22.
4
Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
J Trop Pediatr. 2010 Apr;56(2):122-4. doi: 10.1093/tropej/fmp073. Epub 2009 Aug 5.
5
Non-healing old world cutaneous leishmaniasis caused by L. infantum in a patient from Spain.
BMC Infect Dis. 2014 Apr 16;14:206. doi: 10.1186/1471-2334-14-206.
6
A case of imported Leishmania infantum cutaneous leishmaniasis; an unusual presentation occurring 19 years after travel.
BMC Infect Dis. 2014 Nov 27;14:597. doi: 10.1186/s12879-014-0597-x.
7
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Antimicrob Agents Chemother. 1999 Dec;43(12):2910-4. doi: 10.1128/AAC.43.12.2910.
8
FIRST REPORT OF CUTANEOUS LEISHMANIASIS CAUSED BY Leishmania (Leishmania) infantum chagasi IN AN URBAN AREA OF RIO DE JANEIRO, BRAZIL.
Rev Inst Med Trop Sao Paulo. 2015 Sep-Oct;57(5):451-4. doi: 10.1590/S0036-46652015000500016.
9
Cutaneous leishmaniasis caused by Leishmania infantum in Southern Israel.
Acta Parasitol. 2016 Dec 1;61(4):855-858. doi: 10.1515/ap-2016-0118.
10
Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.
Am J Trop Med Hyg. 2004 Jul;71(1):71-2.
引用本文的文献
1
Progress and Prospects of Triazoles in Advanced Therapies for Parasitic Diseases.
Trop Med Infect Dis. 2025 May 20;10(5):142. doi: 10.3390/tropicalmed10050142.
2
Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major.
Indian J Med Res. 2024 Nov;160(5):466-478. doi: 10.25259/IJMR_569_2024.
3
Unusual Observations in Leishmaniasis-An Overview.
Pathogens. 2023 Feb 10;12(2):297. doi: 10.3390/pathogens12020297.
4
Potency and Preclinical Evidence of Synergy of Oral Azole Drugs and Miltefosine in an Model of () Infection.
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0142521. doi: 10.1128/AAC.01425-21. Epub 2021 Oct 25.
5
Effect of Adjunctive Topical Liposomal Azithromycin on Systemic Azithromycin on Old World Cutaneous Leishmaniasis: A Pilot Clinical Study.
Iran J Pharm Res. 2021 Spring;20(2):383-389. doi: 10.22037/ijpr.2020.113710.14445.
6
Synthesis and Antileishmanial Evaluation of Arylimidamide-Azole Hybrids Containing a Phenoxyalkyl Linker.
ACS Infect Dis. 2021 Jul 9;7(7):1901-1922. doi: 10.1021/acsinfecdis.0c00855. Epub 2021 Feb 4.
7
Disruption of Intracellular Calcium Homeostasis as a Therapeutic Target Against .
Front Cell Infect Microbiol. 2020 Feb 14;10:46. doi: 10.3389/fcimb.2020.00046. eCollection 2020.
8
Effective Tetradentate Compound Complexes against spp. that Act on Critical Enzymatic Pathways of These Parasites.
Molecules. 2018 Dec 31;24(1):134. doi: 10.3390/molecules24010134.
9
Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
J Med Chem. 2018 Dec 13;61(23):10910-10921. doi: 10.1021/acs.jmedchem.8b01671. Epub 2018 Nov 30.
10
CYP51 as drug targets for fungi and protozoan parasites: past, present and future.
Parasitology. 2018 Dec;145(14):1820-1836. doi: 10.1017/S0031182018000562. Epub 2018 Apr 12.
本文引用的文献
1
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.
PLoS Negl Trop Dis. 2010 Apr 6;4(4):e651. doi: 10.1371/journal.pntd.0000651.
2
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus.
Am J Trop Med Hyg. 2010 Apr;82(4):583-7. doi: 10.4269/ajtmh.2010.09-0620.
3
Treatment of cutaneous leishmaniasis in travelers 2009.
J Travel Med. 2009 Mar-Apr;16(2):123-31. doi: 10.1111/j.1708-8305.2008.00286.x.
4
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
J Med Chem. 2006 Feb 9;49(3):892-9. doi: 10.1021/jm050691f.
5
Drug resistance in leishmaniasis.
Clin Microbiol Rev. 2006 Jan;19(1):111-26. doi: 10.1128/CMR.19.1.111-126.2006.
6
Treatment of cutaneous leishmaniasis among travellers.
J Antimicrob Chemother. 2004 Feb;53(2):158-66. doi: 10.1093/jac/dkh058. Epub 2004 Jan 16.
7
Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases.
Antimicrob Agents Chemother. 1999 Dec;43(12):2910-4. doi: 10.1128/AAC.43.12.2910.
8
Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
Antimicrob Agents Chemother. 1998 Jul;42(7):1771-7. doi: 10.1128/AAC.42.7.1771.
9
Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.
Parasitology. 1997;114 Suppl:S91-9.
10
Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
Antimicrob Agents Chemother. 1996 Dec;40(12):2785-91. doi: 10.1128/AAC.40.12.2785.
Zotero 插件